Skip to main content
COLL logo

COLL · Collegium Pharmaceutical, Inc · Analyst Estimates

Track COLL — free
Market Cap
$718.50M
Shares
32.56M

Analyst Estimates

Compare analyst forecasts for Collegium Pharmaceutical, Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 21:27 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
6.65
7.3705
7.72
7.53225
7.7198
7.46575
7.7198
EPS
analysts
Publication date not stated
6
4
1
0
0
Revenue
USD
Publication date not stated
830000000
836111330
845398000
Revenue
analysts
Publication date not stated
6

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
4.52
6.6155
8.11
6.9745
7.6116
6.76575
7.6116
EPS
analysts
Publication date not stated
6
3
1
1
0
Revenue
USD
Publication date not stated
727400000
842514670
906000000
Revenue
analysts
Publication date not stated
6

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.49
1.822
2.01
1.86667
2.0766
1.8605
2.0766
EPS
analysts
Publication date not stated
6
4
0
0
0
Revenue
USD
Publication date not stated
215300000
217968000
222000000
Revenue
analysts
Publication date not stated
6

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.49
1.91617
2.09
2.00333
2.2046
1.99175
2.2046
EPS
analysts
Publication date not stated
6
4
0
0
0
Revenue
USD
Publication date not stated
221000000
224644000
230000000
Revenue
analysts
Publication date not stated
6
Key facts CIK 1267565 CUSIP 19459J104 13F (30d) 7 filings 7 filers Visit website Investor relations